Histamine-2-Receptor Antagonist Administration and Gastrointestinal Bleeding When Used for Stress Ulcer Prophylaxis in Patients With Severe Sepsis or Septic Shock

Annals of Pharmacotherapy

Volumn 48, Issue 10, 2014, Pages 1276-1281

  Barletta, Jeffrey F ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

gastrointestinal hemorrhage; histamine h2 antagonist; sepsis; septic shock; stress ulcer prophylaxis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; ICD-9; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; STOMACH PROTECTION; STRESS ULCER; ADULT; CHEMICALLY INDUCED; COMPARATIVE STUDY; PEPTIC ULCER; SEPSIS; SHOCK, SEPTIC;

ADULT; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; PEPTIC ULCER; PROTON PUMP INHIBITORS; RISK FACTORS; SEPSIS; SHOCK, SEPTIC;

EID: 84907353031     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014540513     Document Type: Article

References (12)

1. Dellinger RP,Levy MM,Rhodes A, et al.Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013;41:580-637.
2. Alhazzani W,Alenezi F,Jaeschke RZ,Moayyedi P,Cook DJ.Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.Crit Care Med. 2013;41:693-705.
3. Maclaren R,Reynolds PM,Allen RR.Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.JAMA Intern Med. 2014;174:564-574.
4. Goldberger AL,Amaral LA,Glass L, et al.PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals.Circulation. 2000;101:E215-E220.
5. Saeed M,Villarroel M,Reisner AT, et al.Multiparameter Intelligent Monitoring in Intensive Care II: a public-access intensive care unit database.Crit Care Med. 2011;39:952-960.
6. Ferreira FL,Bota DP,Bross A,Melot C,Vincent JL.Serial evaluation of the SOFA score to predict outcome in critically ill patients.JAMA. 2001;286:1754-1758.
7. Vincent JL,de Mendonca A,Cantraine F, et al.Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.Crit Care Med. 1998;26:1793-1800.
8. Conrad SA,Gabrielli A,Margolis B, et al.Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.Crit Care Med. 2005;33:760-765.
9. Barkun AN,Bardou M,Pham CQ,Martel M.Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.Am J Gastroenterol. 2012;107:507-520.
10. Barletta JF,El-Ibiary SY,Davis LE,Nguyen B,Raney CR.Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile INFECTION.Mayo Clin Proc. 2013;88:1085-1090.
11. Herzig SJ,Howell MD,Ngo LH,Marcantonio ER.Acid-suppressive medication use and the risk for hospital-acquired pneumonia.JAMA. 2009;301:2120-2128.
12. Howell MD,Novack V,Grgurich P, et al.Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.Arch Intern Med. 2010;170:784-790.